Cargando…
In pediatric rheumatologic disease, methotrexate leads to mildly changed bloodwork on the second day after administration
Autores principales: | Hugle, Boris, Fischer, Nadine, Haas, Johannes-Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991882/ https://www.ncbi.nlm.nih.gov/pubmed/35392929 http://dx.doi.org/10.1186/s12969-022-00685-8 |
Ejemplares similares
-
Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis
por: Scheuern, Andrea, et al.
Publicado: (2016) -
Reducing day 3 baseline monitoring bloodwork and ultrasound for patients undergoing timed intercourse and intrauterine insemination treatment cycles
por: O’Driscoll, Victoria, et al.
Publicado: (2021) -
Patient, hospital and environmental costs of unnecessary bloodwork: capturing the triple bottom line of inappropriate care in general surgery patients
por: Spoyalo, Karina, et al.
Publicado: (2023) -
Applied machine learning and artificial intelligence in rheumatology
por: Hügle, Maria, et al.
Publicado: (2020) -
Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing – treatment protocol and preliminary results
por: Höfel, Lea, et al.
Publicado: (2018)